by Peace Chukwu | Jul 6, 2023
Imagine slowly losing control of your body and the muscles necessary to live healthily, until you eventually lose your ability to breathe. This disease is known as Amyotrophic lateral sclerosis, or ALS, and is caused by the degeneration of motor neurons that send...
by Sara M. Nolte | Jun 21, 2023
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...
by Stacey Johnson | Jun 16, 2023
The definition of a rare disease in the U.S. is under 200,000 patients. The 10 per cent of Americans living with a rare disease is equivalent to 30 million people. Put another way, that is close to the entire population of Canada (at 39 million). There are 7,000 –...
by Stacey Johnson | Jun 9, 2023
Courtney Horvath, PhD, is a board certified toxicologist who knows firsthand about toxicity in pediatric oncology treatments. Her son, Colby, was diagnosed with lymphoma at the age of eight, in March 2020, and she has since become an advocate for better cancer...
by Cal Strode | May 18, 2023
Regular readers of Alliance for Regenerative Medicine (ARM) sector reports may have noticed that the organization is taking a new approach to sharing insights on the cell and gene therapy sector. In April, ARM launched a new format for distilling key data and trend...
by Francesco Zangari | May 10, 2023
CRISPR-Cas9 is not only a revolutionary technology, it is also a topic that never ceases to intrigue. From gene editing to agriculture, the possibilities are seemingly endless. In medicine, CRISPR-Cas9 has shown promising results in curing genetic blood disorders and...
Comments